Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Statistics

Total Valuation

KYMR has a market cap or net worth of $2.16 billion. The enterprise value is $1.40 billion.

Market Cap	2.16B
Enterprise Value	1.40B

Important Dates

The next confirmed earnings date is Friday, May 9, 2025, before market open.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

KYMR has 64.94 million shares outstanding. The number of shares has increased by 28.58% in one year.

Current Share Class	64.94M
Shares Outstanding	64.94M
Shares Change (YoY)	+28.58%
Shares Change (QoQ)	+5.07%
Owned by Insiders (%)	1.42%
Owned by Institutions (%)	78.50%
Float	42.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	53.02
Forward PS	45.37
PB Ratio	2.58
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	29.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.53, with a Debt / Equity ratio of 0.11.

Current Ratio	7.53
Quick Ratio	7.23
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,030.96

Financial Efficiency

Return on equity (ROE) is -36.38% and return on invested capital (ROIC) is -22.87%.

Return on Equity (ROE)	-36.38%
Return on Assets (ROA)	-20.65%
Return on Invested Capital (ROIC)	-22.87%
Return on Capital Employed (ROCE)	-28.20%
Revenue Per Employee	$250,383
Profits Per Employee	-$1.19M
Employee Count	188
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.44% in the last 52 weeks. The beta is 2.23, so KYMR's price volatility has been higher than the market average.

Beta (5Y)	2.23
52-Week Price Change	-5.44%
50-Day Moving Average	30.68
200-Day Moving Average	40.89
Relative Strength Index (RSI)	64.02
Average Volume (20 Days)	927,611

Short Selling Information

The latest short interest is 7.99 million, so 12.30% of the outstanding shares have been sold short.

Short Interest	7.99M
Short Previous Month	7.84M
Short % of Shares Out	12.30%
Short % of Float	18.66%
Short Ratio (days to cover)	11.65

Income Statement

In the last 12 months, KYMR had revenue of $47.07 million and -$223.86 million in losses. Loss per share was -$2.98.

Revenue	47.07M
Gross Profit	-193.18M
Operating Income	-256.71M
Pretax Income	-157.85M
Net Income	-223.86M
EBITDA	-250.74M
EBIT	-256.71M
Loss Per Share	-$2.98

Balance Sheet

The company has $488.74 million in cash and $87.76 million in debt, giving a net cash position of $763.14 million or $11.75 per share.

Cash & Cash Equivalents	488.74M
Total Debt	87.76M
Net Cash	763.14M
Net Cash Per Share	$11.75
Equity (Book Value)	835.62M
Book Value Per Share	12.88
Working Capital	442.50M

Cash Flow

In the last 12 months, operating cash flow was -$194.50 million and capital expenditures -$12.84 million, giving a free cash flow of -$207.34 million.

Operating Cash Flow	-194.50M
Capital Expenditures	-12.84M
Free Cash Flow	-207.34M
FCF Per Share	-$3.19

Margins

Gross Margin	n/a
Operating Margin	-545.36%
Pretax Margin	-475.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KYMR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.58%
Shareholder Yield	-28.58%
Earnings Yield	-10.36%
FCF Yield	-9.60%

Analyst Forecast

The average price target for KYMR is $56.69, which is 70.27% higher than the current price. The consensus rating is "Buy".

Price Target	$56.69
Price Target Difference	70.27%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	65.78%
EPS Growth Forecast (5Y)	-1.90%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KYMR has an Altman Z-Score of 9.14 and a Piotroski F-Score of 2.

Altman Z-Score	9.14
Piotroski F-Score	2